JP2013519690A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013519690A5 JP2013519690A5 JP2012553146A JP2012553146A JP2013519690A5 JP 2013519690 A5 JP2013519690 A5 JP 2013519690A5 JP 2012553146 A JP2012553146 A JP 2012553146A JP 2012553146 A JP2012553146 A JP 2012553146A JP 2013519690 A5 JP2013519690 A5 JP 2013519690A5
- Authority
- JP
- Japan
- Prior art keywords
- immunoglobulin
- pharmaceutical composition
- composition according
- antibody
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/707,297 US20100209341A1 (en) | 2009-02-18 | 2010-02-17 | Treatment of chronic inflammatory conditions |
| US12/707,297 | 2010-02-17 | ||
| US37449710P | 2010-08-17 | 2010-08-17 | |
| US37448910P | 2010-08-17 | 2010-08-17 | |
| US61/374,489 | 2010-08-17 | ||
| US61/374,497 | 2010-08-17 | ||
| PCT/AU2011/000155 WO2011100786A1 (en) | 2010-02-17 | 2011-02-17 | Compositions and methods for targeting type 1 interferon producing cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013519690A JP2013519690A (ja) | 2013-05-30 |
| JP2013519690A5 true JP2013519690A5 (enExample) | 2014-04-03 |
| JP6018507B2 JP6018507B2 (ja) | 2016-11-02 |
Family
ID=44482392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012553146A Active JP6018507B2 (ja) | 2010-02-17 | 2011-02-17 | Ｉ型インターフェロン産生細胞を標的化するための組成物及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2536430B1 (enExample) |
| JP (1) | JP6018507B2 (enExample) |
| KR (1) | KR101842907B1 (enExample) |
| CN (1) | CN103002913B (enExample) |
| AU (1) | AU2011217728B2 (enExample) |
| CA (1) | CA2789810C (enExample) |
| ES (1) | ES2618562T3 (enExample) |
| IL (1) | IL221504B (enExample) |
| NZ (2) | NZ610826A (enExample) |
| WO (1) | WO2011100786A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100209341A1 (en) | 2009-02-18 | 2010-08-19 | Csl Limited | Treatment of chronic inflammatory conditions |
| EP2839842A1 (en) | 2013-08-23 | 2015-02-25 | MacroGenics, Inc. | Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof |
| CN120988137A (zh) | 2015-01-23 | 2025-11-21 | 赛诺菲 | 抗cd3抗体、抗cd123抗体和与cd3和/或cd123特异性结合的双特异性抗体 |
| TW201709932A (zh) * | 2015-06-12 | 2017-03-16 | 西雅圖遺傳學公司 | Ｃｄ１２３抗體及其共軛物 |
| US11499168B2 (en) * | 2016-04-25 | 2022-11-15 | Universitat Basel | Allele editing and applications thereof |
| US20220002370A1 (en) | 2018-09-27 | 2022-01-06 | Xilio Development, Inc. | Masked cytokine polypeptides |
| WO2022115865A2 (en) | 2020-11-25 | 2022-06-02 | Xilio Development, Inc. | Tumor-specific cleavable linkers |
| TWI905354B (zh) | 2020-12-31 | 2025-11-21 | 法商英耐特醫藥公司 | 結合至NKp46及CD123之多功能自然殺手 (NK) 細胞接合體 |
| KR20250017240A (ko) | 2022-05-27 | 2025-02-04 | 사노피 | FC-조작을 갖는 NKp46 및 BCMA 변이체에 결합하는 자연 살해(NK) 세포 관여자 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050013810A1 (en) * | 2001-05-08 | 2005-01-20 | Waller Edmund K | Regulating immune response using dendritic cells |
| US7612181B2 (en) * | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| ES2987072T3 (es) * | 2006-09-07 | 2024-11-13 | Scott & White Memorial Hospital | Métodos y composiciones basados en conjugados de toxina diftérica-interleucina-3 |
| JP2008162954A (ja) * | 2006-12-28 | 2008-07-17 | Kirin Pharma Co Ltd | 形質細胞様樹状細胞特異的膜分子に対する抗体を含む治療剤 |
| US8163279B2 (en) * | 2007-04-13 | 2012-04-24 | Stemline Therapeutics, Inc. | IL3Rα antibody conjugates and uses thereof |
| WO2009070844A1 (en) * | 2007-12-06 | 2009-06-11 | Csl Limited | Method of inhibition of leukemic stem cells |
| US20100209341A1 (en) * | 2009-02-18 | 2010-08-19 | Csl Limited | Treatment of chronic inflammatory conditions |
-
2011
- 2011-02-17 AU AU2011217728A patent/AU2011217728B2/en active Active
- 2011-02-17 NZ NZ610826A patent/NZ610826A/en unknown
- 2011-02-17 JP JP2012553146A patent/JP6018507B2/ja active Active
- 2011-02-17 KR KR1020127024197A patent/KR101842907B1/ko active Active
- 2011-02-17 CA CA2789810A patent/CA2789810C/en active Active
- 2011-02-17 NZ NZ601760A patent/NZ601760A/xx not_active IP Right Cessation
- 2011-02-17 ES ES11744183.2T patent/ES2618562T3/es active Active
- 2011-02-17 EP EP11744183.2A patent/EP2536430B1/en active Active
- 2011-02-17 WO PCT/AU2011/000155 patent/WO2011100786A1/en not_active Ceased
- 2011-02-17 CN CN201180016427.5A patent/CN103002913B/zh active Active
-
2012
- 2012-08-16 IL IL221504A patent/IL221504B/en active IP Right Grant